Selective elimination of autoreactive lymphocytes with immunotoxins

Research output: Contribution to journalArticle

Abstract

A variety of diseases are the result of identifiable cell types entering an abnormal state of development in which they escape existing mechanisms that regulate their growth or other functional activities. A variety of investigators interested in eliminating cells that have undergone malignant transformation have devised immunotherapeutic approaches based on the construction of hybrid molecules composed of highly toxic biological poisons covalently coupled with antibodies specific for membrane antigens expressed selectively by tumor cell targets. This strategy can be further exploited to eliminate any target cell with defined, selectively expressed membrane antigens. The following discussion describes possible uses of such an approach for achieving selective cytotoxicity of lymphocytes with undesirable immunoreactivities, such as those found in autoimmune disease and graft-versus-host disease.

Original languageEnglish (US)
Pages (from-to)273-282
Number of pages10
JournalClinical Immunology and Immunopathology
Volume50
Issue number3
DOIs
StatePublished - 1989

Fingerprint

Immunotoxins
Lymphocytes
Poisons
Antigens
Membranes
Graft vs Host Disease
Autoimmune Diseases
Research Personnel
Antibodies
Growth
Neoplasms

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Pathology and Forensic Medicine

Cite this

Selective elimination of autoreactive lymphocytes with immunotoxins. / Krolick, Keith A.

In: Clinical Immunology and Immunopathology, Vol. 50, No. 3, 1989, p. 273-282.

Research output: Contribution to journalArticle

@article{2dcb790bcebe451185404e85709cc156,
title = "Selective elimination of autoreactive lymphocytes with immunotoxins",
abstract = "A variety of diseases are the result of identifiable cell types entering an abnormal state of development in which they escape existing mechanisms that regulate their growth or other functional activities. A variety of investigators interested in eliminating cells that have undergone malignant transformation have devised immunotherapeutic approaches based on the construction of hybrid molecules composed of highly toxic biological poisons covalently coupled with antibodies specific for membrane antigens expressed selectively by tumor cell targets. This strategy can be further exploited to eliminate any target cell with defined, selectively expressed membrane antigens. The following discussion describes possible uses of such an approach for achieving selective cytotoxicity of lymphocytes with undesirable immunoreactivities, such as those found in autoimmune disease and graft-versus-host disease.",
author = "Krolick, {Keith A}",
year = "1989",
doi = "10.1016/0090-1229(89)90136-0",
language = "English (US)",
volume = "50",
pages = "273--282",
journal = "Clinical Immunology",
issn = "1521-6616",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Selective elimination of autoreactive lymphocytes with immunotoxins

AU - Krolick, Keith A

PY - 1989

Y1 - 1989

N2 - A variety of diseases are the result of identifiable cell types entering an abnormal state of development in which they escape existing mechanisms that regulate their growth or other functional activities. A variety of investigators interested in eliminating cells that have undergone malignant transformation have devised immunotherapeutic approaches based on the construction of hybrid molecules composed of highly toxic biological poisons covalently coupled with antibodies specific for membrane antigens expressed selectively by tumor cell targets. This strategy can be further exploited to eliminate any target cell with defined, selectively expressed membrane antigens. The following discussion describes possible uses of such an approach for achieving selective cytotoxicity of lymphocytes with undesirable immunoreactivities, such as those found in autoimmune disease and graft-versus-host disease.

AB - A variety of diseases are the result of identifiable cell types entering an abnormal state of development in which they escape existing mechanisms that regulate their growth or other functional activities. A variety of investigators interested in eliminating cells that have undergone malignant transformation have devised immunotherapeutic approaches based on the construction of hybrid molecules composed of highly toxic biological poisons covalently coupled with antibodies specific for membrane antigens expressed selectively by tumor cell targets. This strategy can be further exploited to eliminate any target cell with defined, selectively expressed membrane antigens. The following discussion describes possible uses of such an approach for achieving selective cytotoxicity of lymphocytes with undesirable immunoreactivities, such as those found in autoimmune disease and graft-versus-host disease.

UR - http://www.scopus.com/inward/record.url?scp=0024573726&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024573726&partnerID=8YFLogxK

U2 - 10.1016/0090-1229(89)90136-0

DO - 10.1016/0090-1229(89)90136-0

M3 - Article

VL - 50

SP - 273

EP - 282

JO - Clinical Immunology

JF - Clinical Immunology

SN - 1521-6616

IS - 3

ER -